This means GLP-1 promotes insulin release only when blood glucose levels are elevated, reducing the risk of hypoglycemia compared to some other diabetes medications
When administering the lower dose of Semaglutide at 1 mg to treat patients with diabetes, the SUSTAIN study consistently demonstrated significant improvements in glucose control and body weight reduction 29,30,31,32,33,34,35
Most people notice improvements in energy levels and oxygen transport within 2-4 weeks of consistent use
Customized Plans for Individual Needs Your weight-loss plan considers your body chemistry, metabolism, medical history, and lifestyle
A LeanMD physician will review your health profile and recommend the most appropriate medication paired with a complete muscle-protecting, results-lasting weight loss program